The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
MDR3 P-glycoprotein, a Phosphatidylcholine Translocase, Transports Several Cytotoxic Drugs and Directly Interacts with Drugs as Judged by Interference with Nucleotide Trapping
Open accessAbstract
The human MDR3 gene is a member of the multidrug resistance (MDR) gene family. The MDR3 P-glycoprotein is a transmembrane protein that translocates phosphatidylcholine. The MDR1 P-glycoprotein related transports cytotoxic drugs. Its overexpression can make cells resistant to a variety of drugs. Attempts to show that MDR3 P-glycoprotein can cause MDR have been unsuccessful thus far. Here, we report an increased directional transport of several MDR1 P-glycoprotein substrates, such as digoxin, paclitaxel, and vinblastine, through polarized monolayers of MDR3-transfected cells. Transport of other good MDR1 P-glycoprotein substrates, including cyclosporin A and dexamethasone, was not detectably increased. MDR3 P-glycoprotein-dependent transport of a short-chain phosphatidylcholine analog and drugs was inhibited by several MDR reversal agents and other drugs, indicating an interaction between these compounds and MDR3 P-gp. Insect cell membranes from Sf9 cells overexpressing MDR3 showed specific MgATP binding and a vanadate-dependent, N-ethylmaleimide-sensitive nucleotide trapping activity, visualized by covalent binding with [alpha-(32)P]8-azido-ATP. Nucleotide trapping was (nearly) abolished by paclitaxel, vinblastine, and the MDR reversal agents verapamil, cyclosporin A, and PSC 833. We conclude that MDR3 P-glycoprotein can bind and transport a subset of MDR1 P-glycoprotein substrates. The rate of MDR3 P-glycoprotein-mediated transport is low for most drugs, explaining why this protein is not detectably involved in multidrug resistance. It remains possible, however, that drug binding to MDR3 P-glycoprotein could adversely affect phospholipid or toxin secretion under conditions of stress (e.g. in pregnant heterozygotes with one MDR3 null allele).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION
Bligh, E. G., & Dyer, W. J. (1959) · Canadian Journal of Biochemistry and Physiology · doi:10.1139/o59-099 · Cited by 54,751
Chen, C.-J., Chin, J. E., Ueda, K., Clark, D. P., Pastan, I., Gottesman, M. M., & Roninson, I. B. (1986) · Cell · doi:10.1016/0092-8674(86)90595-7 · Cited by 1,898
Smit, J. J. M., Schinkel, A. H., Elferink, R. P. J. O., Groen, A. K., Wagenaar, E., van Deemter, L., Mol, C. A. A. M., Ottenhoff, R., van der Lugt, N. M. T., van Roon, M. A., et al. (1993) · Cell · doi:10.1016/0092-8674(93)90380-9 · Cited by 1,456
Self-citationSchinkel, A. H., Wagenaar, E., van Deemter, L., Mol, C. A., & Borst, P. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118214 · Cited by 1,107
Self-citationSchinkel, A. H., Mayer, U., Wagenaar, E., Mol, C. A. A. M., van Deemter, L., Smit, J. J. M., van der Valk, M. A., Voordouw, A. C., Spits, H., van Tellingen, O., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.8.4028 · Cited by 937
Self-citationvan Helvoort, A., Smith, A. J., Sprong, H., Fritzsche, I., Schinkel, A. H., Borst, P., & van Meer, G. (1996) · Cell · doi:10.1016/s0092-8674(00)81370-7 · Cited by 855
Self-citationMutations in the MDR 3 gene cause progressive familial intrahepatic cholestasis
de Vree, J. M. L., Jacquemin, E., Sturm, E., Cresteil, D., Bosma, P. J., Aten, J., Deleuze, J.-F., Desrochers, M., Burdelski, M., Bernard, O., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.1.282 · Cited by 735
The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump.
Zaman, G. J., Flens, M. J., van Leusden, M. R., de Haas, M., Mülder, H. S., Lankelma, J., Pinedo, H. M., Scheper, R. J., Baas, F., & Broxterman, H. J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.19.8822 · Cited by 680
Human P-glycoprotein transports cortisol, aldosterone, and dexamethasone, but not progesterone.
Ueda, K., Okamura, N., Hirai, M., Tanigawara, Y., Saeki, T., Kioka, N., Komano, T., & Hori, R. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)35757-0 · Cited by 673
Sarkadi, B., Price, E. M., Boucher, R. C., Germann, U. A., & Scarborough, G. A. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42909-2 · Cited by 632
Self-citationPhosphatidylcholine translocase: A physiological role for the mdr2 gene
Ruetz, S. (1994) · Cell · doi:10.1016/0092-8674(94)90446-4 · Cited by 599
GENETIC ANALYSIS OF THE MULTIDRUG TRANSPORTER
Gottesman, M. M., Hrycyna, C. A., Schoenlein, P. V., Germann, U. A., & Pastan, I. (1995) · Annual Review of Genetics · doi:10.1146/annurev.ge.29.120195.003135 · Cited by 478
P-glycoprotein—A mediator of multidrug resistance in tumour cells
Germann, U. A. (1996) · European Journal of Cancer · doi:10.1016/0959-8049(96)00057-3 · Cited by 405
Th, M., van Nieuwkerk, C. M., Dingemans, K. P., Smit, J. J., Schinkel, A. H., Notenboom, R. G. E., Weerman, M. A. V. D. B., VERKRUISEN, R. P., Groen, A. K., & Elferink, R. P. J. O. (1994) · PubMed · Cited by 403
Detection of P-glycoprotein isoforms by gene-specific monoclonal antibodies.
Georges, E., Bradley, G., Gariepy, J., & Ling, V (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.1.152 · Cited by 384
Heterozygous non-sense mutation of the MDR3 gene in familial intrahepatic cholestasis of pregnancy
Jacquemin, E., Cresteil, D., Manouvrier, S., Boute, O., & Hadchouel, M. (1999) · The Lancet · doi:10.1016/s0140-6736(05)77221-4 · Cited by 367
Urbatsch, I. L., Sankaran, B., Weber, J., & Senior, A. E. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.33.19383 · Cited by 363
Tanigawara, Y., Okamura, N., Hirai, M., Yasuhara, M., Ueda, K., Kioka, N., Komano, T., & Hori, R. (1992) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10423-0 · Cited by 337
Sequence of mdr3 cDNA encoding a human P-glycoprotein
van der Bliek, A. M., Kooiman, P. M., Schneider, C., & Borst, P. (1988) · Gene · doi:10.1016/0378-1119(88)90057-1 · Cited by 289
Self-citationVan der Bliek, A. M., Baas, F., Ten Houte de Lange, T., Kooiman, P. M., Van der Velde-Koerts, T., & Borst, P. (1987) · The EMBO Journal · doi:10.1002/j.1460-2075.1987.tb02653.x · Cited by 281
Self-citationSmith, A. J., Timmermans-Hereijgers, J. L. P. M., Roelofsen, B., Wirtz, K. W. A., van Blitterswijk, W. J., Smit, J. J. M., Schinkel, A. H., & Borst, P. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)01135-4 · Cited by 280
Self-citationMayer, U., Wagenaar, E., Dorobek, B., Beijnen, J. H., Borst, P., & Schinkel, A. H. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119784 · Cited by 269
Self-citationCloning and characterization of a second member of the mouse mdr gene family.
Gros, P., Raymond, M., Bell, J., & Housman, D. (1988) · Molecular and Cellular Biology · doi:10.1128/mcb.8.7.2770 · Cited by 266
Evers, R., Zaman, G. J., van Deemter, L., Jansen, H., Calafat, J., Oomen, L. C., Oude Elferink, R. P., Borst, P., & Schinkel, A. H. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118535 · Cited by 260
Self-citationMultidrug Resistance in Cancer
Kartner, N., & Ling, V. (1989) · Scientific American · doi:10.1038/scientificamerican0389-44 · Cited by 251
Both P-glycoprotein Nucleotide-binding Sites Are Catalytically Active
Urbatsch, I. L., Sankaran, B., Bhagat, S., & Senior, A. E. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.45.26956 · Cited by 225
N-glycosylation and deletion mutants of the human MDR1 P-glycoprotein.
Schinkel, A. H., Kemp, S., Dollé, M., Rudenko, G., & Wagenaar, E. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53199-9 · Cited by 214
Schinkel, A. H., Roelofs, E. M., & Borst, P. (1991) · PubMed · Cited by 205
Self-citationHerweijer, H., Sonneveld, P., Baas, F., & Nooter, K. (1990) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/82.13.1133 · Cited by 201
Genes amplified and overexpressed in human multidrug-resistant cell lines.
van der Bliek, A. M., Baas, F. F., der Velde-Koerts, T. V., et al. (1988) · PubMed · Cited by 173
Crawford, A. R., Smith, A. J., Hatch, V., Elferink, R. P. J. O., Borst, P., & Crawford, J. M. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119799 · Cited by 155
Self-citationRaggers, R. J., van Helvoort, A., Evers, R., & Gerrit van, M. E. E. R. (1999) · Journal of Cell Science · doi:10.1242/jcs.112.3.415 · Cited by 155
Structure of the human MDR3 gene and physical mapping of the human MDR locus.
Lincke, C. R., Smit, J., der Velde-Koerts, T. V., & Borst, P. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)67788-4 · Cited by 137
Self-citationSmith, A. J., Vree, M., Ottenhoff, R., Elferink, R. P. J. O., Schinkel, A. H., & Borst, P. (1998) · Hepatology · doi:10.1002/hep.510280234 · Cited by 123
Self-citationExpression of the human multidrug transporter in insect cells by a recombinant baculovirus
Germann, U. A., Willingham, M. C., Pastan, I. H., et al. (1990) · Biochemistry · doi:10.1021/bi00461a013 · Cited by 120
Multidrug resistance of cancer cells
Kane, S. E. (1996) · Advances in Drug Research · doi:10.1016/s0065-2490(96)80005-0 · Cited by 91
Enhancement of Mdr2-mediated Phosphatidylcholine Translocation by the Bile Salt Taurocholate
Ruetz, S., & Gros, P. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.43.25388 · Cited by 85
Drug-stimulated Nucleotide Trapping in the Human Multidrug Transporter MDR1
Szabó, K., Welker, E., Bakos, É., Müller, M., Roninson, I. B., Váradi, A., & Sarkadi, B. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.17.10132 · Cited by 84
Self-citationSmith, A. J., Mayer, U., Schinkel, A. H., & Borst, P. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.15.1161 · Cited by 72
Self-citationSorting of newly synthesized galactosphingolipids to the two surface domains of epithelial cells.
van der Bijl, P., Lopes-Cardozo, M., & Gerrit van, M. E. E. R. (1996) · The Journal of Cell Biology · doi:10.1083/jcb.132.5.813 · Cited by 57
Kino, K., Taguchi, Y., Yamada, K., Komano, T., & Ueda, K. (1996) · FEBS Letters · doi:10.1016/s0014-5793(96)01265-3 · Cited by 54
Use of recombinant P-glycoprotein fragments to produce antibodies to the multidrug transporter
Tanaka, S., Currier, S. J., Bruggemann, E. P., et al. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(90)91928-l · Cited by 54
van Genderen, I., & Gerrit van, M. E. E. R. (1995) · The Journal of Cell Biology · doi:10.1083/jcb.131.3.645 · Cited by 47
Cited by
Targeting multidrug resistance in cancer
Szakács, G., Paterson, J. K., Ludwig, J. A., Booth-Genthe, C., & Gottesman, M. M. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1984 · Cited by 3,609
“, and MDR3 has been shown to promote the transcellular transport of several Pgp substrates, such as digoxin, paclitaxel and vinblastin”
BackgroundSelf-citationMammalian ABC Transporters in Health and Disease
Borst, P., & Elferink, R. O. (2002) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.71.102301.093055 · Cited by 1,571
Self-citationRole of P-Glycoprotein in Pharmacokinetics: Clinical Implications
Lin, J. H., & Yamazaki, M. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342010-00003 · Cited by 998
ABC Multidrug Transporters: Structure, Function and Role in Chemoresistance
Sharom, F. J. (2008) · Pharmacogenomics · doi:10.2217/14622416.9.1.105 · Cited by 973
Sarkadi, B., Homolya, L., Szakács, G., & Váradi, A. (2006) · Physiological Reviews · doi:10.1152/physrev.00037.2005 · Cited by 726
Self-citation
Metadata
- Authors
- Smith, A. J., van Helvoort, A., van Meer, G., Szabó, K., Welker, E., Szakács, G., Váradi, A., Sarkadi, B., & Borst, P.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2000-08
- Volume
- 275
- Issue
- 31
- Pages
- 23530-23539
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2131851850
- Cited by
- 252
- References
- 43
- FWCI
- 4.46
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.